Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1953 1
1959 1
1962 1
1964 2
1965 2
1966 3
1967 2
1968 3
1969 2
1970 2
1971 2
1972 2
1973 2
1974 4
1975 12
1976 11
1977 18
1978 21
1979 38
1980 26
1981 22
1982 27
1983 31
1984 41
1985 35
1986 31
1987 25
1988 28
1989 29
1990 16
1991 30
1992 20
1993 21
1994 16
1995 30
1996 38
1997 27
1998 28
1999 26
2000 32
2001 41
2002 44
2003 48
2004 44
2005 50
2006 72
2007 62
2008 73
2009 83
2010 68
2011 83
2012 79
2013 77
2014 61
2015 83
2016 73
2017 85
2018 55
2019 69
2020 65
2021 57
2022 79
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

2,036 results
Results by year
Filters applied: . Clear all
Page 1
Acne treatment review and future perspectives.
Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. Mohsin N, et al. Dermatol Ther. 2022 Sep;35(9):e15719. doi: 10.1111/dth.15719. Epub 2022 Jul 26. Dermatol Ther. 2022. PMID: 35841269 Review.
There are abundant topical and oral treatment options available for patients with acne. First-line agents include topical retinoids, azelaic acid, benzoyl peroxide, and combinations of these agents. For recalcitrant or more severe acne, oral medications, including o …
There are abundant topical and oral treatment options available for patients with acne. First-line agents include topical retinoids, azelaic …
A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne.
Bassett IB, Pannowitz DL, Barnetson RS. Bassett IB, et al. Med J Aust. 1990 Oct 15;153(8):455-8. doi: 10.5694/j.1326-5377.1990.tb126150.x. Med J Aust. 1990. PMID: 2145499 Clinical Trial.
We have performed a single-blind, randomised clinical trial on 124 patients to evaluate the efficacy and skin tolerance of 5% tea-tree oil gel in the treatment of mild to moderate acne when compared with 5% benzoyl peroxide lotion. The results of this study showed t …
We have performed a single-blind, randomised clinical trial on 124 patients to evaluate the efficacy and skin tolerance of 5% tea-tree oil g …
Management of Severe Acne Vulgaris With Topical Therapy.
Stein Gold L, Baldwin HE, Lin T. Stein Gold L, et al. J Drugs Dermatol. 2017 Nov 1;16(11):1134-1138. J Drugs Dermatol. 2017. PMID: 29141062 Review.
However, studies assessing the treatment of moderate-to-severe acne include subpopulation data in severe patients. Adapalene 0.3%-benzoyl peroxide (BP) 2.5% was found to be effective in patients with severe acne, whereas the fixed combination with a lower concentrat …
However, studies assessing the treatment of moderate-to-severe acne include subpopulation data in severe patients. Adapalene 0.3%-benzoyl
Systematic review of antibiotic resistance in acne: an increasing topical and oral threat.
Walsh TR, Efthimiou J, Dréno B. Walsh TR, et al. Lancet Infect Dis. 2016 Mar;16(3):e23-33. doi: 10.1016/S1473-3099(15)00527-7. Epub 2016 Feb 5. Lancet Infect Dis. 2016. PMID: 26852728 Free article. Review.
Oral antibiotics still have a role in the treatment of moderate-to-severe acne, but only with a topical retinoid, benzoyl peroxide, or their combination, and ideally for no longer than 3 months. To limit resistance, it is recommended that benzoyl peroxide
Oral antibiotics still have a role in the treatment of moderate-to-severe acne, but only with a topical retinoid, benzoyl peroxide
Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris.
Dréno B, Layton AM, Troielli P, Rocha M, Chavda R. Dréno B, et al. Eur J Dermatol. 2022 Jul 1;32(4):445-450. doi: 10.1684/ejd.2022.4275. Eur J Dermatol. 2022. PMID: 36301750 Review. English.
Adapalene, a synthetic topical retinoid, is available in two concentrations (0.1% and 0.3%) and in once-daily fixed-dose combinations with benzoyl peroxide (BPO) 2.5%. Adapalene 0.3%/BPO 2.5% is approved for use for moderate-to-severe acne with proven efficacy, good …
Adapalene, a synthetic topical retinoid, is available in two concentrations (0.1% and 0.3%) and in once-daily fixed-dose combinations with …
Benzoyl peroxide.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1999;71 Pt 2(PT 2):345-58. IARC Monogr Eval Carcinog Risks Hum. 1999. PMID: 10476451 Free PMC article. Review. No abstract available.
Intense pulsed light versus benzoyl peroxide.
Al Abdullah MJ, Mahdi YG. Al Abdullah MJ, et al. J Popul Ther Clin Pharmacol. 2022 Jan 10;28(2):e54-e61. doi: 10.47750/jptcp.2022.856. eCollection 2022. J Popul Ther Clin Pharmacol. 2022. PMID: 35044116 Clinical Trial.
Patients were categorized into two groups: (a) 20 patients in Group A treated with IPL for 3 sessions, 3 weeks apart, (b) and 27 patients in Group B treated with benzoyl peroxide (BPO) 2.5% gel daily at night for 9 weeks. Follow up was done at 3 weeks after the end …
Patients were categorized into two groups: (a) 20 patients in Group A treated with IPL for 3 sessions, 3 weeks apart, (b) and 27 patients in …
Benzoyl peroxide.
Cotterill JA. Cotterill JA. Acta Derm Venereol Suppl (Stockh). 1980;Suppl 89:57-63. Acta Derm Venereol Suppl (Stockh). 1980. PMID: 6162349 Clinical Trial.
The mode of action of benzoyl peroxide in acne is three-fold, i.e. sebostatic, comedolytic and inhibitory to P. acnes in-vivo. Benzoyl peroxide is the topical treatment of choice in acne vulgaris. ...
The mode of action of benzoyl peroxide in acne is three-fold, i.e. sebostatic, comedolytic and inhibitory to P. acnes in-vivo. …
Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.
Mills OH Jr, Kligman AM, Pochi P, Comite H. Mills OH Jr, et al. Int J Dermatol. 1986 Dec;25(10):664-7. doi: 10.1111/j.1365-4362.1986.tb04534.x. Int J Dermatol. 1986. PMID: 2948929 Clinical Trial.
A 2.5% formulation of benzoyl peroxide was compared with its vehicle, and with a 5% and a 10% proprietary benzoyl peroxide gel preparation in three double-blind studies involving 153 patients with mild to moderately severe acne vulgaris. The 2.5% be
A 2.5% formulation of benzoyl peroxide was compared with its vehicle, and with a 5% and a 10% proprietary benzoyl pe
2,036 results